The proper formation of synaptic connectivity in the mammalian brain is critical for complex behavior. In the striatum, balanced excitatory synaptic transmission from multiple sources onto two classes of principal neurons is required for coordinated and voluntary motor control. Here we show that the interaction between the secreted semaphorin 3E (Sema3E) and its receptor Plexin-D1 is a critical determinant of synaptic specificity in cortico-thalamo-striatal circuits in mice. We find that Sema3e (encoding Sema3E) is highly expressed in thalamostriatal projection neurons, whereas in the striatum Plxnd1 (encoding Plexin-D1) is selectively expressed in direct-pathway medium spiny neurons (MSNs). Despite physical intermingling of the MSNs, genetic ablation of Plxnd1 or Sema3e results in functional and anatomical rearrangement of thalamostriatal synapses specifically in direct-pathway MSNs without effects on corticostriatal synapses. Thus, our results demonstrate that Sema3E and Plexin-D1 specify the degree of glutamatergic connectivity between a specific source and target in the complex circuitry of the basal ganglia. npg *
One of the noteworthy features of the central nervous system is the precision of synaptic connections, which is essential for the proper formation of functional circuits and the generation of complex behavior and cognitive function. During development, after axons have navigated long distances to reach their targets, they choose appropriate synaptic partners and, in many cases, also select a domain of the postsynaptic cell on which to form synapses 1, 2 . The challenges of achieving the proper synapse specificity of wiring in the mammalian brain are evident in the striatum. As the input nucleus of the basal ganglia, the striatum receives convergent excitatory inputs carrying motor, sensory and cognitive information from the cortex and thalamus. Specific excitatory synaptic connections need to be formed between axons arising from these two areas and two functionally distinct but anatomically intermingled populations of targets, direct and indirect pathway striatal MSNs 3 . The proper balance of excitatory synaptic transmission onto direct and indirect pathway MSNs is required for coordinated and voluntary motor function, and imbalances of synaptic strength are thought to contribute to neuropsychiatric diseases such as Parkinson's disease and attention deficit hyperactivity disorder 4 .
Direct and indirect pathway MSNs are functionally and molecularly distinct, despite being physically intermixed and having similar electrophysiological and morphological properties 5, 6 . Direct pathway MSNs express type 1 dopamine receptors (Drd1a) and their activity promotes motor action, whereas indirect pathway MSNs express type 2 dopamine receptors (Drd2) and their activity suppresses action initiation 7 . Individual direct and indirect pathway MSNs receive input from both cortex and thalamus [8] [9] [10] [11] ; likewise, individual cortical and thalamic axons innervate both classes of MSN 10, 11 . However, cortical and thalamic projections differ in several aspects. Cortical boutons express the vGluT1 vesicular glutamate transporter, have lower probability of release and nearly always form synapses onto the heads of dendritic spines. In contrast, thalamic axons express the vGluT2 vesicular glutamate transporter, have higher probability of release and form fewer synapses, which are nearly equally distributed between the dendritic shaft and dendritic spine heads 9, 11, 12 .
Our understanding of synapse specification-that is, how a specific synaptic target is selected from among many-mainly arises from studies of laminar specificity. In some parts of the mammalian CNS such as the retina and hippocampus, functionally similar neuronal subtypes are anatomically segregated and arranged into a stereotypic laminar organization. A prevailing model emerging from studies of Caenorhabditis elegans and of laminar specificity in the retina is that synapse specificity is established by a direct interaction between presynaptic and postsynaptic protein partners that comprise a complementary set of recognition molecules 1, [13] [14] [15] [16] [17] [18] . These signaling pairs can mediate positive adhesive interactions that direct axons to particular laminae. Alternatively, postsynaptic target laminae establish a concentration gradient of secreted or transmembrane proteins to repel innervation by inappropriate inputs. However, in many regions of the mammalian brain including the striatum, heterogeneous populations of neurons are intermingled, rendering secretion of a repellent signal by target neurons insufficient to direct synapse selection.
In this study, we find that the in vivo interaction between a traditional axon repulsive cue, Sema3E, and its receptor, Plexin-D1, determines synaptic specificity in cortico-thalamo-striatal circuits. We show that Sema3E is secreted by thalamostriatal axons and Plexin-D1 is selectively expressed by one subtype of postsynaptic neuron, the direct pathway MSN. Genetic ablation of Plxnd1 or Sema3e affects glutamatergic synapses formed onto direct pathway MSNs without affecting synapses onto indirect pathway MSNs. Furthermore, electrophysiological and optogenetic analyses reveal that thalamostriatal innervation of direct pathway MSNs is specifically strengthened in a r t I C l e S Plxnd1 mutant mice. These changes are accompanied by increased density of immunohistochemical markers of thalamostriatal synapses onto direct pathway MSNs, indicating that Sema3E-Plexin-D1 signaling normally restricts the number of these synapses. Thus, Sema3E and Plexin-D1 serve as a molecular recognition system to control specific synaptic connections in the complex circuitry of the basal ganglia.
RESULTS

Complementary expression of Sema3e and Plxnd1
We found complementary patterns of expression of Sema3e and Plxnd1 in the cortex-thalamus-striatum circuit (Fig. 1) . In situ hybridization (ISH) revealed that Plxnd1 was highly expressed in the striatum at postnatal day (P) 3 ( Fig. 1a,b) . Conversely, Sema3e was expressed in the thalamus and sparsely in deep cortical layers, the two principal sources of glutamatergic inputs to the striatum. In vivo retrograde labeling of thalamostriatal projection neurons with DiI and subsequent Sema3e ISH revealed that Sema3e was expressed in many of these neurons, particularly in the parafascicular and centromedian intralaminar nuclei ( Fig. 1c,d) , the main thalamic nuclei that project to the striatum 9 . Neuropilin-1, a co-receptor for Sema3E that modulates Sema3E-Plexin-D1 signaling in other systems 19 , was absent in the striatum (Supplementary Fig. 1 ), suggesting that Plexin-D1 acts independently as a receptor for Sema3E in this brain region.
Striatal Plxnd1 expression was maintained during early postnatal life (P0-P8; Fig. 1e ,f) and diminished to undetectable levels by P14-P25 ( Supplementary Fig. 2) . Thus, Plxnd1 is expressed in the striatum during the developmental stage when initial synaptogenesis occurs [20] [21] [22] . The postnatal and complementary expression patterns of Plxnd1 and Sema3e in the striatum and thalamostriatal projecting neurons, respectively, suggest that they may influence the formation and refinement of glutamatergic synapses.
Plexin-D1 is selectively expressed in direct pathway MSNs
To determine whether Plxnd1 is expressed selectively in one class of MSNs, we used double fluorescence ISH to examine the expression of Plxnd1 in the striatum of transgenic mice that exploit the cell-type specific expression of dopamine receptor subtypes to express GFP by means of a bacterial artificial chromosome (BAC) selectively in either direct pathway (Drd1a-GFP) or indirect pathway (Drd2-GFP) MSNs ( Fig. 2 and Supplementary Fig. 3 ) 23 . In P3 Drd1a-GFP mice, the expression of Plxnd1 in the striatum overlapped with that of GFP, such that ~85% of all direct pathway MSNs expressed Plxnd1 (Fig. 2a,c) . In contrast, Plxnd1 expression did not overlap with that of GFP in Drd2-GFP mice (Fig. 2b,c) , indicating an absence of expression in indirect pathway MSNs. The cell-by-cell correlation coefficients of GFP and Plxnd1 expression levels were 0.8 in Drd1a-GFP and 0.1 in Drd2-GFP mice (n = 7 sections; P < 0.05, Mann-Whitney; Fig. 2d ).
To confirm that most Plxnd1 expression is confined to direct pathway MSNs, we quantified Plxnd1 in the striatum of mice in which Plxnd1 was selectively deleted in direct or indirect pathway MSNs by crossing mice carrying a loxP-flanked ('floxed') Plxnd1 gene (Plxnd1 f/f mice) with Drd1a-cre or Drd2-cre mice, respectively. Drd2-GFP;Drd1a-cre;Plxnd1 f/f (referred to as direct pathway mutant) and Drd2-GFP;Drd2-cre;Plxnd1 f/f (indirect pathway mutant) mice were viable and fertile, permitting studies of synapse formation at postnatal stages. ISH revealed that striatal Plxnd1 expression was significantly reduced in direct pathway mutant mice compared to wild-type littermate controls (8.7% ± 2.9% of control, n = 12 and n = 10 sections from control and Drd1a-cre;Plxnd1 f/f mice, respectively; P < 0.05, Mann-Whitney; Fig. 2e,f) . In contrast, there was no difference in Plxnd1 expression in indirect pathway mutant mice (86.1% ± 7.6% of control, n = 6 sections each from control and Drd2-cre;Plxnd1 f/f mice; P > 0.05, Mann-Whitney; Fig. 2g,h) . These data demonstrate that, in the striatum, Plxnd1 is expressed selectively in direct pathway MSNs and is thus a potential molecular cue to differentially control glutamatergic synapse formation onto these two cell classes.
Deletion of Plxnd1 or Sema3e perturbs synapse function
To test whether Sema3e and Plxnd1 are required for synapse formation in vivo, we examined glutamatergic synapses onto direct and indirect MSNs in the pathway-specific Plxnd1 conditional knockout mice (direct pathway mutant Drd2-GFP;Drd1a-cre;Plxnd1 f/f and indirect pathway mutant Drd2-GFP;Drd2-cre;Plxnd1 f/f ). The use of Drd2-GFP mice enables identification of direct and indirect pathway MSNs in the striatum based on the absence and presence, respectively, npg a r t I C l e S of GFP expression. To determine whether deletion of Plxnd1 alters the numbers of glutamatergic synapses formed onto MSNs, we examined two proxies of synapse number. First, to assess the number of active synapses, we measured AMPA receptor-mediated spontaneous miniature excitatory postsynaptic currents (mEPSCs) using wholecell voltage-clamp recordings. Loss of Plxnd1 in direct pathway MSNs led to a large and significant (P < 0.05, Mann-Whitney) increase in mEPSC frequency in direct pathway MSNs (direct pathway mutant, 2.20 ± 0.25 Hz; n = 12 cells) compared to either Cre-negative (Plxnd1 f/f (f/f ctrl), 1.39 ± 0.21 Hz; n = 6 cells) or Cre-positive control neurons (Drd1a-cre;Plxnd1 f/+ (het ctrl), 1.07 ± 0.14 Hz; n = 12 cells) without significant changes in mEPSC amplitude (10.9 ± 0.5 pA; f/f ctrl, 10.3 ± 1.1 pA; het ctrl, 10.1 ± 0.3 pA; direct pathway mutant. 10.9 ± 0.5 pA; P > 0.05, Mann-Whitney) ( Fig. 3a-c) . Similar analysis demonstrated that loss of Plxnd1 in indirect pathway MSNs did not cause significant changes in mEPSC frequency (f/f ctrl, 2.14 ± 0.37 Hz, n = 5 cells; het ctrl, 1.99 ± 0.17 Hz, n = 10 cells; indirect pathway mutant, 2.11 ± 0.16 Hz, n = 8 cells; P > 0.05, Mann-Whitney) or amplitude (f/f ctrl, 12.0 ± 1.1 pA; het ctrl, 10.9 ± 0.6 pA; indirect pathway mutant, 11.0 ± 0.5 pA; P > 0.05, Mann-Whitney) ( Fig. 3d-f ). These results suggest that loss of Plxnd1 increases presynaptic vesicular release probability or the number of active glutamatergic synapses formed onto direct pathway MSNs without effect on indirect pathway MSNs, indicating that Plexin-D1 negatively regulates synapses in direct pathway MSNs. Second, we imaged MSNs in acute brain slices using two-photon laser-scanning microscopy (2PLSM) to measure the density of dendritic spines. In MSNs, the large majority of cortical glutamatergic inputs are formed onto dendritic spines and the majority of spines are associated with corticostriatal synapses, such that changes in the number of spines are thought to parallel changes in the number of corticostriatal synapses. We filled Plxnd1 null and control MSNs with the red fluorophore Alexa Fluor-594 through a whole-cell recording pipette and imaged dendritic branches (50-80 µm from soma) ( Fig. 4a) . To our surprise, in contrast to the increase in frequency of mEPSCs, loss of Plxnd1 in direct pathway MSNs led to a small (~17%) but significant (P < 0.05, Mann-Whitney) decrease in spine density in direct pathway MSNs (0.87 ± 0.03 spines µm −1 ; n = 38 dendrites in 9 cells) compared to control direct pathway neurons (f/f ctrl, 1.10 ± 0.03 spines µm −1 , n = 16 dendrites in 6 cells; het ctrl, 1.05 ± 0.03 spines µm −1 , n = 35 dendrites in 8 cells; Fig. 4b,c ). Similar analysis of MSNs in indirect pathway mutants revealed no change (P > 0.05, Mann-Whitney) in spine density (f/f ctrl, 1.06 ± 0.03 spines µm −1 , n = 16 dendrites in 5 cells; het ctrl, 1.11 ± 0.04 spines µm −1 , n = 19 dendrites in 6 cells; indirect pathway mutant, 1.02 ± 0.03 spines µm −1 , n = 32 dendrites in 8 cells; Fig. 4b,c ). No significant changes in spine length, width or head area were observed in either mutant ( Supplementary Fig. 4) .
To test whether loss of Plexin-D1 affects dendrite morphology, we traced Alexa Fluor-594-filled striatal MSNs and measured dendritic length and branching ( Supplementary Fig. 5 ). In the absence of Plxnd1, Scholl analysis revealed a slight increase in complexity of dendrites in direct pathway MSNs (P < 0.05 for dendritic segments 70-95 µm from soma; n = 10 in control and 11 in mutant mice; Mann-Whitney) but not in the indirect pathway MSNs (Supplementary Fig. 5 ). The resulting small increase in total dendrite length counteracted the decreased dendritic spine density such that estimates of the total spine number (density × length) were similar in control and Plxnd1-lacking direct pathway MSNs (1,591.8 ± 74.3 and 1,496.4 ± 127.4 spines, respectively). These data indicate that the large increase in mEPSC frequency in direct pathway MSNs caused by loss of Plexin-D1 is accompanied by only minor structural changes and is thus unlikely to result from a greater number of glutamatergic synapses formed on dendritic spines.
To determine whether Sema3E, a known Plexin-D1 ligand 24 , is required for synapse formation in direct pathway MSNs, we analyzed Fig. 6 ). Thus, loss of Sema3E selectively alters glutamatergic synapses in direct pathway MSNs, phenocopying the effects of Plexin-D1 loss. These results support the conclusion that Sema3E is the ligand for Plexin-D1 in the striatum and that the interaction between Sema3E and Plexin-D1 controls synapse formation in the direct pathway MSNs.
Postnatal Plxnd1 expression regulates synapse formation
Although it is possible that the synaptic defects observed in the Plxnd1 conditional knockout mice are due to loss of Plxnd1 function in early development, rather than a direct function of Plexin-D1 (Fig. 6a) . ISH 4-6 d after unilateral injection revealed substantial downregulation of Plxnd1 in the infected areas of Plxnd1 f/f mice (Supplementary Fig. 7) .
We examined synaptic strength and spine density in direct and indirect pathway MSNs 2 to 3 weeks after AAV-Cre-mCherry injection. Data were collected from spiny GFP-positive and GFP-negative neurons that showed distinct red fluorescence in the nucleus, indicating expression of the Cre-mCherry fusion (Fig. 6b,c) . Electrophysiological analysis in these mice revealed phenotypes that were essentially identical to those of the Plxnd1 direct-pathwayspecific conditional knockout mice: increased frequency of mEPSCs in Plxnd1 mutant direct pathway MSNs (control, 1.31 ± 0.18 Hz, n = 12; Plxnd1 null, 2.16 ± 0.27 Hz, n = 11; P < 0.05, Mann-Whitney) without significant differences in amplitude (control, 13.2 ± 1.1 pA; Plxnd1 null, 13.2 ± 0.67 pA; P > 0.05, Mann-Whitney) ( Fig. 6d,e) . In contrast, in indirect pathway MSNs we saw no difference in mEPSC frequency (control, 2.57 ± 0.58 Hz, n = 7; Plxnd1 null, 2.32 ± 0.26 Hz, n = 6; P > 0.05, Mann-Whitney) or amplitude (control, 13.8 ± 2.3 pA, n = 7; Plxnd1 null, 13.4 ± 1.5 pA, n = 6; P > 0.05, Mann-Whitney; Fig. 6d,f) after loss of Plxnd1. Similarly to what was found in pathway-specific Plxnd1 conditional null mice ( Fig. 4) , loss of Plxnd1 decreased spine density ~15% in direct pathway MSNs (control, 0.94 ± 0.04 spines µm −1 , n = 37 dendrites in 10 cells; Plxnd1 null, 0.80 ± 0.04 spines µm −1 , n = 37 dendrites in 9 cells; P < 0.05) but had no effect on indirect pathway MSNs (control, 1.06 ± 0.03 spines µm −1 , n = 26 dendrites in 7 cells; Plxnd1 null, 1.09 ± 0.04 spines µm −1 , n = 18 dendrites in 6 cells; P > 0.05, Mann-Whitney) (Fig. 6g,h) . No significant changes in spine length, width and head area were observed between control and Plxnd1 null MSNs of either pathway (P > 0.05, Mann-Whitney; Supplementary Fig. 8) . Thus, postnatal loss of Plxnd1 produced a similar synaptic phenotype-increased mEPSC rate and slightly decreased spine density-in direct pathway MSNs to that of constitutive loss of Plxnd1 in the direct pathway conditional null mice, demonstrating that Plexin-D1 regulates postnatal synapse formation in direct pathway MSNs.
Sema3E-Plexin-D1 signaling controls synapse specificity
Because Sema3e is expressed highly in the thalamus and sparsely in deep layers of the cortex, we examined whether the synaptic alternations observed in Sema3e and Plxnd1 mutant mice reflect defects in specific subsets of glutamatergic synapses formed onto direct pathway MSNs. Loss of Plxnd1 in direct pathway MSNs has only little effect on spine number and density while nearly doubling mEPSC frequency, suggesting either that the distribution of synapses onto dendritic spine heads versus those onto aspiny regions of the cell has shifted or that postsynaptic loss of Plxnd1 increases the probability of release from innervating glutamatergic fibers. Of note, corticostriatal inputs are formed predominantly onto spine heads, whereas only ~50% of thalamostriatal axons form synapses onto spine heads 9, 11 . Furthermore, the probability of neurotransmitter release is typically lower at corticostriatal than at thalamostriatal synapses 10 . Therefore, it is possible that postsynaptic loss of Plxnd1 in direct pathway MSNs selectively triggers an increase in thalamostriatal inputs, which would increase mEPSC rate despite no net changes in total number of spines. To directly test this hypothesis, we separately examined glutamatergic synapses formed onto MSNs by cortical and thalamic axons. Excitatory postsynaptic currents (EPSCs) were recorded in direct and indirect pathway MSNs from direct pathway mutant Drd2-GFP;Drd1a-cre;Plxnd1 f/f mice and from Drd2-GFP;Drd1a-cre;Plxnd1 f/+ littermate or wild type controls. To achieve specific activation of thalamostriatal axons, AAV encoding fluorophore-tagged Channelrhodopsin-2 (ChR2-mCherry) was injected into the parafasicular nucleus of the thalamus (Fig. 7a,b) . Three to 4 weeks after virus injection, thalamostriatal axons expressing ChR2-mCherry were prominent in the striatum and could be identified in acute brain slices (Fig. 7c) .
To detect possible changes in synaptic strength, we recorded EPSCs in neighboring direct and indirect pathway MSNs (<50 µm apart) simultaneously (10 pairs) or sequentially (14 pairs) ( Fig. 7d-i) . In control mice, optogenetic activation of thalamostriatal axons elicited robust EPSCs in direct and indirect pathway MSNs of similar 
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-/- Fig. 7d,e ), suggesting that thalamic neurons similarly innervate both MSN classes. In contrast, in direct pathway mutant mice, we observed larger evoked thalamostriatal EPSCs in direct pathway MSNs than in neighboring indirect pathway MSNs (EPSC ratio direct/indirect, 1.83 ± 0.26, n = 6 pairs; P < 0.05 compared to control; Fig. 7d,e) . Paired-pulse stimulation at a 50-ms inter-stimulus interval with blue light yielded no change in paired-pulse ratios (direct pathway control, 0.61 ± 0.10, n = 6; direct pathway mutant, 0.44 ± 0.16, n = 6; P > 0.05, Mann-Whitney; indirect pathway control, 0.27 ± 0.10; direct pathway mutant, 0.39 ± 0.07, n = 6; P > 0.05, Mann-Whitney). Therefore, loss of Plxnd1 in direct pathway MSNs enhanced thalamostriatal synaptic strength in direct pathway MSNs relative to that in indirect pathway MSNs. Similar analysis using electrical stimulation of corticostriatal inputs revealed that cortically evoked EPSCs had similar amplitudes in neighboring direct and indirect pathway MSNs of control mice (EPSC ratio direct/indirect, 1.05 ± 0.17; P > 0.05, n = 6 pairs, Wilcoxon) ( Fig. 7f,g) . However, in contrast to the above findings, we did not observe significant differences in evoked corticostriatal EPSCs between direct and indirect pathway MSNs from direct pathway mutant mice (EPSC ratio direct/indirect, 1.05 ± 0.08; P > 0.05, n = 6 pairs, Wilcoxon). In addition, paired-pulse stimuli revealed no changes in paired-pulse ratios between control and mutant MSNs (direct pathway control, 1.44 ± 0.36, n = 6; direct pathway mutant, 1.08 ± 0.11, n = 6; P > 0.05, Mann-Whitney; indirect pathway control, 1.13 ± 0.11, n = 6; direct pathway mutant, 1.05 ± 0.09, n = 6; P > 0.05, Mann-Whitney).
To exclude the possibility that electrical stimulation could not reveal subtle changes in corticostriatal transmission, we stimulated corticostriatal inputs using ChR2. We injected AAV encoding ChR2-mCherry into motor cortex and recorded pairs of direct and indirect pathway MSNs 4 weeks after virus injection. Optogenetic activation of corticostriatal axons evoked similar-size EPSCs in direct and indirect pathway MSNs from control and direct pathway mutant mice (control EPSC ratio direct/indirect. 1.05 ± 0.03, n = 7 pairs; P > 0.05, Wilcoxon; direct pathway mutant EPSC ratio direct/indirect, 0.94 ± 0.06, n = 5 pairs; P > 0.05, Wilcoxon) ( Fig. 7h,i) . Thus, postsynaptic expression of Plxnd1 in direct pathway MSNs selectively controls synaptic strength of thalamostriatal but not corticostriatal inputs. Specifically, Sema3E-Plexin-D1 signaling negatively regulates synaptic strength of thalamostriatal synapses onto direct pathway MSNs. Such changes in direct pathway Plxnd1 mutant mice enhance the excitatory drive from thalamus to the direct pathway 26 , possibly contributing to reduced basal locomotion and exploration of the central open area of an arena seen in direct pathway Plxnd1 mutant mice (Supplementary Fig. 9 ).
Loss of Plxnd1 increases thalamostriatal synapse number
To directly test whether the number of thalamostriatal synapses onto direct pathway MSNs increased in the absence of Plexin-D1, Quantitation of the number of thalamostriatal synapses was performed in ultrathin (100 nm) slices, which substantially improves the resolution and reduces superimposition of fluorescent puncta in different focal planes 27 . To mark a sparse subset of direct pathway MSNs with a space-filling fluorophore, we injected AAV carrying double-floxed inverted GFP into the striatum of het ctrl (Drd1acre;Plxnd1 f/+ ) and direct pathway mutant (Drd1a-cre;Plxnd1 f/f ) mice. It is necessary to use sparse labeling, as marking all direct pathway MSNs results in a dense background of green fluorescence. However, this approach constrains the analysis to GFP-expressing neurons because unlabeled MSNs cannot be unambiguously assigned to the direct or indirect pathway.
Putative thalamostriatal synapses were identified as closely apposed presynaptic (vGluT2-positive) and postsynaptic (GluR1positive) puncta (Fig. 8) . We observed an increase in such puncta (Fig. 8a,b) in direct pathway mutant mice compared to controls. Furthermore, only a small number of vGluT2-positive puncta were found on the somata of control direct pathway MSNs, whereas vGluT2-postive puncta densely covered the somata of mutant direct pathway MSNs (Fig. 8c,d) . Automated image analysis indicated that the density of colocalized GluR1-vGluT2 puncta that overlapped with GFP-positive regions was significantly greater (P < 0.0001, Mann-Whitney) in direct pathway mutant mice (0.347 ± 0.007 µm −2 , n = 236 sections in 8 slices) compared to control (0.125 ± 0.004 µm −2 , n = 320 sections in 9 slices) ( Fig. 8e) . Thus, the number of immunohistochemically identified putative thalamostriatal synapses was increased in Plxnd1 null direct pathway MSNs, further npg a r t I C l e S supporting the conclusion that Sema3E-Plexin-D1 signaling normally inhibits thalamostriatal synapse formation. Furthermore, the dense perisomatic innervation in the direct pathway mutant mice likely contributes to the markedly increased mEPSC rate in the mutant mice, as somatic synapses are electronically close to the recording electrode and are therefore detected at a higher rate than synapses formed onto thin dendrites.
DISCUSSION
Our results demonstrate that the specificity of glutamatergic synaptic connectivity in the striatum is controlled by target-and sourcespecific expression of a ligand-receptor pair, Sema3E and Plexin-D1. Plexin-D1 is selectively expressed in direct but not in indirect pathway MSNs and thereby provides a mechanism to control synapse formation in a subset of functionally distinct but anatomically intermixed postsynaptic neurons. The ligand, secreted Sema3E, is highly expressed in the thalamus but only sparsely expressed in deep layers of cortex 28 , which allows selective action on synapses between a particular pair of neuronal classes. Disruption of Sema3E-Pleixin-D1 signaling in vivo results in functional and anatomical rearrangement of thalamostriatal synapses specifically in direct pathway MSNs without affecting the strength of corticostriatal innervation. Together the thalamic expression of Sema3e and direct pathway-specific expression of Plxnd1 underlie a molecular recognition mechanism that selectively restricts thalamostriatal synapse formation.
Our understanding of the molecular mechanisms of synapse specificity has mainly come from studies of brain areas in which neurons of a specific class are organized into well defined subdivisions 14, [16] [17] [18] . For example, in the inner plexiform layer of the mouse retina, transmembrane semaphorin 6A is expressed in ON sublamina and its receptor Plexin-A4 is expressed in adjacent OFF sublamina. The repulsive nature of the interaction between these transmembrane proteins ensures that Plexin-A4 -positive axons do not innervate the ON sublamina and results in lamina-specific neurite stratification 17 . Similarly, in the mouse spinal cord, Sema3E secreted by neurons of the cutaneous maximus motor pool signals through Plexin-D1 expressed by a subset of proprioceptive afferents to repel these axons 18 . In both examples, anatomically clustered postsynaptic neurons express repulsive ligands that prevent innervation by inappropriate axons. However, in the striatum, cortical and thalamic axons as well as direct and indirect pathway MSNs are intermixed, rendering establishment of a uniform repellent signal by target neurons insufficient to direct synapse selection. Notably, in thalamostriatal projections the orientation of receptor and ligand expression is reversed, such that Sema3E is secreted by axons and Plexin-D1 is expressed by one subtype of postsynaptic neuron. Therefore, although the protein families of the receptor-ligand pair are conserved, the logic of establishing synapse specificity in the striatum is different from that previously described in the retina and spinal cord.
The electrophysiological and anatomical data presented here indicate that Sema3E-Plexin-D1 signaling negatively regulates thalamostriatal synapse formation. Of note, this regulation is graded in the sense that Plxnd1 expression modulates the strength of thalamic inputs, rather than rejecting all inputs from the thalamus. Furthermore, the increase in mEPSC rate without large changes in spine density, dendritic arborization or corticostriatal synaptic strength suggest that loss of Sema3E-Plexin-D1 signaling increases the number of thalamostriatal glutamatergic synapses formed onto the somata and the dendritic shafts of direct pathway MSNs. This possibility is supported by estimates of thalamostriatal synapse density in direct pathway MSNs using array tomography-based immunohistochemical analysis (Fig. 8) . This specificity may arise by selective localization of Plexin-D1 protein to a subcellular compartment of the direct pathway MSNs. Indeed, previous studies have shown that both neuropilins and Plexin-A2 are expressed with inhomogeneous subcellular distributions 29, 30 .
Despite the consistent small decrease in dendritic spine density of direct pathway MSNs seen upon the loss of Plxnd1 or Sema3e, we were unable to detect a significant change in corticostriatal innervation of these cells. This may be because spine density is a measure of synapse density on the dendrite, whereas the amplitudes of evoked synaptic currents are proportional to the total number of synapses formed onto the cell. Therefore, the changes to the dendrites of Plxnd1-lacking neurons might leave total synapse number relatively unaffected despite a decrease in synapse density. Furthermore, a difficult-to-detect small reduction of corticostriatal transmission would be in contrast to the strengthening of thalamostriatal synapses, indicating input-specific regulation of synapse formation in the striatum.
Because secreted Sema3E is expressed by thalamostriatal axons, it is unlikely that Sema3E-Plexin-D1 signaling directly affects the targeting of the axon. Instead, Sema3E-Plexin-D1 signaling may control thalamostriatal synaptic strength by regulating the receptivity of direct pathway MSNs to thalamic inputs, such as by triggering postsynaptic signaling cascades that alter the cytoskeleton or regulate glutamate receptor trafficking and stabilization. For example, the small GTPases Rac and Rho are involved in Plexin-B1 function 31 and regulate synapse and spine formation in many neuron classes 31, 32 . An alternative model is that Sema3E-dependent activation of postsynaptic Plexin-D1 may induce production of a retrograde signal that repels thalamostriatal axons [33] [34] [35] .
The proper balance of excitatory synapses formed by cortical and thalamic neurons onto direct and indirect pathway MSNs is crucial for a variety of behaviors, such as locomotion, anxiety, attention orientation, motor learning and reward [36] [37] [38] . The thalamostriatal pathway has been suggested to mediate salient environmental information and regulate motor behavior 39, 40 . Consistent with our results showing an increased number of thalamostriatal synapses, we observed changes in basal locomotor behavior in Plxnd1 direct pathway mutant mice (Supplementary Fig. 9 ). Direct pathway mutant mice traveled less distance than controls, showed longer delays to enter the central open quadrant of an area and spent less time in that quadrant, suggesting that changes in thalamostriatal synapses can lead to increased anxiety and decreased basal locomotion.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/. 
